Breast lumps differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(23 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Breast lumps}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Breast_lumps]]
{{CMG}}; {{AE}} {{S.M}}
{{CMG}}; {{AE}} {{S.M}}, {{SSH}}


==Overview==
==Overview==
[[Breast lumps]] must be differentiated from other diseases such as [[malignancy]], [[cysts]], [[inflammation]] and non-inflammatory solid lumps. Breast symptoms such as [[nipple discharge]] and [[mastalgia]] require assessment as well.
[[Breast lumps]] must be differentiated from other diseases such as [[malignancy]], [[cysts]], [[inflammation]] and non-inflammatory solid lumps. Breast symptoms such as [[nipple discharge]] and [[mastalgia]] require assessment as well. Differentiating different types of breast lumps are based on imaging findings and breast clinical exam results.
==Differentiating Breast lumps from other Diseases==
==Differentiating Breast lumps from other Diseases==
Differential diagnosis of [[breast lumps]] include:
<small>'''ABBREVIATIONS'''<br>LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ</small>
 
<small>
{|
{|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Benign or
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Benign
Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="8" |Clinical manifestation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="9" |Clinical manifestation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="2" |Paraclinical findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="3" |Paraclinical findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="3" |Associated findings
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="3" |Symptoms
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="3" |Symptoms
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="4" |Signs
! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="3" |Signs
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |Imaging
Line 31: Line 30:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref>
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
* Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]]
* Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common [[benign]] [[tumor]], women aged 20-30 years
* Most common [[benign]] [[tumor]], women aged 20-30 years
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Increased in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]]
* Increases in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
Line 52: Line 48:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* Proliferative breast lesion without [[atypia]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Proliferative [[breast]] lesion without [[atypia]]
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Well-defined
* Well-defined
* Solid mass
* Solid mass
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]] [[Ultrasound]]   
* [[Mammography]]
* [[Ultrasound]]   
* [[Biopsy]]
* [[Biopsy]]
| align="center" style="background:#F5F5F5;" |NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Hormonal]] fluctuation
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]] for simple [[cyst]]
* No increased risk of [[malignancy]] for simple [[cyst]]
* <1% for complicated [[cyst]]
* <1% for complicated [[cyst]]
Line 77: Line 69:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* May resolve after aspiration
* May resolve after aspiration
* Further evaluation for not completely resolved masses
* Further evaluation for unresolved masses
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
Line 84: Line 76:
* Solitary
* Solitary
* Cluster of small masses or an ill-defined mass
* Cluster of small masses or an ill-defined mass
* Smooth, firm, and frequently tender
* Smooth, firm, and frequently [[Tenderness|tender]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* Nonproliferative breast lesions
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes  
* Nonproliferative [[breast]] lesions
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes  
* Complicated [[cyst]]: Homogenous low-level internal echoes due to without solid components
* Complicated [[cyst]]: Homogenous low-level internal echoes due to without solid components
* Complex [[cyst]]: Thick walls greater than 0.5 mm with solid component
* Complex [[cyst]]: Thick walls greater than 0.5 mm with solid component
Line 98: Line 88:
* [[Ultrasound]]
* [[Ultrasound]]
* [[Fine needle aspiration]] ([[FNA]])  
* [[Fine needle aspiration]] ([[FNA]])  
|NA
|-
|-
! align="center" style="background:#DCDCDC;" |Fibrocystic change<ref name="pmid10693180">{{cite journal| author=Templeman C, Hertweck SP| title=Breast disorders in the pediatric and adolescent patient. | journal=Obstet Gynecol Clin North Am | year= 2000 | volume= 27 | issue= 1 | pages= 19-34 | pmid=10693180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10693180  }}</ref>
! align="center" style="background:#DCDCDC;" |Fibrocystic change<ref name="pmid10693180">{{cite journal| author=Templeman C, Hertweck SP| title=Breast disorders in the pediatric and adolescent patient. | journal=Obstet Gynecol Clin North Am | year= 2000 | volume= 27 | issue= 1 | pages= 19-34 | pmid=10693180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10693180  }}</ref>
| align="left" style="background:#F5F5F5;" |
* Unknown
* Imbalance between [[estrogen]] and [[progesterone]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" left" |
| align="left" style="background:#F5F5F5;" left" |
* [[Benign]]
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
* Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]]
* Slightly increased risk of [[malignancy]] in presence of positive [[familial history]] of [[breast cancer]]
Line 112: Line 98:
* >50% in women of reproductive age
* >50% in women of reproductive age
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Become present before menses and improve during mensturation
* Present before menses and improve during [[menstruation]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Painful breast tissue
* Painful [[breast]] tissue
* Tender, [[nodular]] swelling
* Tender, [[nodular]] swelling
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* Nonproliferative breast lesions
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nonproliferative [[breast]] lesions
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Small [[cysts]] in [[mammary]] zone
* Small [[cysts]] in [[mammary]] zone
* Fibroglandular tissue around the mass
* Fibroglandular tissue around the mass
Line 131: Line 115:
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]] (it is not recommended for adolescents)
* [[Mammography]] (it is not recommended for adolescents)
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue=  | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid24327995">{{cite journal| author=Yu JH, Kim MJ, Cho H, Liu HJ, Han SJ, Ahn TG| title=Breast diseases during pregnancy and lactation. | journal=Obstet Gynecol Sci | year= 2013 | volume= 56 | issue= 3 | pages= 143-59 | pmid=24327995 | doi=10.5468/ogs.2013.56.3.143 | pmc=3784111 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24327995  }}</ref><ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue=  | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221  }}</ref>
| align="left" style="background:#F5F5F5;" |
* Milk duct [[obstruction]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
Line 151: Line 132:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Retention [[cyst]] resulting from lactiferous duct occlusion
* [[Inflammation]] of lactate ducts due to extension, results in wall [[fibrosis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* [[Mammography]]: Intermediate mass in absence of classic fat-fluid level
* Intermediate mass in absence of classic fat-fluid level
* [[Ultrasound]]: Complex mass
[[Ultrasound]]:
* Complex mass
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Cysts]] of [[Glands of Montgomery|montgomery]]<ref name="pmid17174833">{{cite journal| author=De Silva NK, Brandt ML| title=Disorders of the breast in children and adolescents, Part 2: breast masses. | journal=J Pediatr Adolesc Gynecol | year= 2006 | volume= 19 | issue= 6 | pages= 415-8 | pmid=17174833 | doi=10.1016/j.jpag.2006.09.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17174833  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Cysts]] of [[Glands of Montgomery|montgomery]]<ref name="pmid17174833">{{cite journal| author=De Silva NK, Brandt ML| title=Disorders of the breast in children and adolescents, Part 2: breast masses. | journal=J Pediatr Adolesc Gynecol | year= 2006 | volume= 19 | issue= 6 | pages= 415-8 | pmid=17174833 | doi=10.1016/j.jpag.2006.09.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17174833  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Obstruction]] of periareolar [[Glands of Montgomery|glands of montgomery]]
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
Line 182: Line 159:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Acute]] [[inflammation]] due to [[obstruction]] of the [[Montgomery's glands|Montgomery's gland]]
* [[Acute]] [[inflammation]] due to [[obstruction]] of the [[Montgomery's glands|Montgomery's gland]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Single [[cystic]] lesion in retroareolar area
* Single [[cystic]] lesion in retroareolar area
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
* Coexisting [[malignancy]] may be present
| align="left" style="background:#F5F5F5;" |
* Coexisting [[malignancy]] can occur
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common in women older than 35 years old
* Common in women older than 35 years old
Line 208: Line 180:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Soft [[breast lump]]
* Soft [[breast lump]]
* Breast enlargement without palpable mass
* [[Breast]] enlargement without palpable mass
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] proliferation of [[fibrous]], [[glandular]], and fatty tissue
* [[Benign]] proliferation of [[fibrous]], [[glandular]], and fatty tissue
* Thin capsule of [[connective tissue]]
* Thin capsule of [[connective tissue]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* Well-described  
* Well-described  
* Discrete, solid, and encapsulated lesion
* Discrete, solid, and encapsulated lesion
Line 222: Line 192:
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid26095437">{{cite journal| author=D'Alfonso TM, Ginter PS, Shin SJ| title=A Review of Inflammatory Processes of the Breast with a Focus on Diagnosis in Core Biopsy Samples. | journal=J Pathol Transl Med | year= 2015 | volume= 49 | issue= 4 | pages= 279-87 | pmid=26095437 | doi=10.4132/jptm.2015.06.11 | pmc=4508565 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26095437  }}</ref><ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835  }}</ref>
| align="left" style="background:#F5F5F5;" |
* [[Complication]] of [[breast]] [[mastitis]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Complication of lactational [[mastitis]] in 14% of cases
* Complication of lactational [[mastitis]] in 14% of cases
* Common among African American women, heavy smokers , and [[obese]] patients
* Common among African-American women, heavy smokers , and [[obese]] patients
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Resolve after drainage/
* Resolve after drainage/[[antibiotic therapy]]
* anti-biotic therapy
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 245: Line 211:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Fever]]
* Mixed [[inflammatory]] feature by [[neutrophils]].
* [[Malaise]]
* [[Granulation tissue]] and [[chronic]] [[inflammation]] feature caused by [[Gram-positive cocci]]  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* [[Blood culture]] is required in severe [[infection]]
| align="left" style="background:#F5F5F5;" |
* [[Inflammatory]] mass [[Purulent]] material drainage either spontaneously or on [[incision]]
| align="left" style="background:#F5F5F5;" |
* Fluid collection
* Fluid collection
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Mastitis]]<ref name="pmid8696751">{{cite journal| author=Dixon JM, Ravisekar O, Chetty U, Anderson TJ| title=Periductal mastitis and duct ectasia: different conditions with different aetiologies. | journal=Br J Surg | year= 1996 | volume= 83 | issue= 6 | pages= 820-2 | pmid=8696751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8696751  }}</ref><ref name="pmid17267864">{{cite journal| author=Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists| title=ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. | journal=Obstet Gynecol | year= 2007 | volume= 109 | issue= 2 Pt 1 | pages= 479-80 | pmid=17267864 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17267864  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Mastitis]]<ref name="pmid8696751">{{cite journal| author=Dixon JM, Ravisekar O, Chetty U, Anderson TJ| title=Periductal mastitis and duct ectasia: different conditions with different aetiologies. | journal=Br J Surg | year= 1996 | volume= 83 | issue= 6 | pages= 820-2 | pmid=8696751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8696751  }}</ref><ref name="pmid17267864">{{cite journal| author=Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists| title=ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. | journal=Obstet Gynecol | year= 2007 | volume= 109 | issue= 2 Pt 1 | pages= 479-80 | pmid=17267864 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17267864  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Inflammation]]
* [[Benign]]
* [[Infection]]
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
* No increased risk of [[malignancy]]
* No increased risk of [[malignancy]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
Line 268: Line 226:
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Resolve after anti-biotic therapy/
* Resolve after drainage/[[antibiotic therapy]]
drainage
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Breast [[tenderness]]
* [[Breast]] [[tenderness]]
* Swollen [[breast]] [[tissue]]
* Swollen [[breast]] [[tissue]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]]   [[inflammation]]:
* [[Fever]]
* [[Nipple]] [[retraction]]
| align="left" style="background:#F5F5F5;" |
* [[Leukocytosis]]
| align="left" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]:
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]] [[infection]]  
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]] [[infection]]  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Skin thickening
* Skin thickening
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or<br>Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]<ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref><ref name="pmid16175185">{{cite journal |vauthors=Li CI, Uribe DJ, Daling JR |title=Clinical characteristics of different histologic types of breast cancer |journal=Br. J. Cancer |volume=93 |issue=9 |pages=1046–52 |date=October 2005 |pmid=16175185 |pmc=2361680 |doi=10.1038/sj.bjc.6602787 |url=}}</ref><ref name="pmid19764994">{{cite journal |vauthors=Parise CA, Bauer KR, Brown MM, Caggiano V |title=Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 |journal=Breast J |volume=15 |issue=6 |pages=593–602 |date=2009 |pmid=19764994 |doi=10.1111/j.1524-4741.2009.00822.x |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]<ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref><ref name="pmid16175185">{{cite journal |vauthors=Li CI, Uribe DJ, Daling JR |title=Clinical characteristics of different histologic types of breast cancer |journal=Br. J. Cancer |volume=93 |issue=9 |pages=1046–52 |date=October 2005 |pmid=16175185 |pmc=2361680 |doi=10.1038/sj.bjc.6602787 |url=}}</ref><ref name="pmid19764994">{{cite journal |vauthors=Parise CA, Bauer KR, Brown MM, Caggiano V |title=Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 |journal=Breast J |volume=15 |issue=6 |pages=593–602 |date=2009 |pmid=19764994 |doi=10.1111/j.1524-4741.2009.00822.x |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Generally unknown
* [[Malignant]]
* [[Genetic]] factors
* [[Hormonal]] exposure
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common diagnosed [[cancer]] among women
* Most common diagnosed [[cancer]] among women
Line 334: Line 276:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="left" style="background:#F5F5F5;" |
* Breast size changes
* [[Nipple]] abnormality
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Molecular alteration in [[epithelial cells]]
* Molecular alteration in [[epithelial cells]]
Line 347: Line 285:
* [[Medullary]]
* [[Medullary]]
* [[Papillary]]
* [[Papillary]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* [[Mammography]]: Spiculated soft tissue, mass [[microcalcification]]
* Spiculated soft tissue, mass [[microcalcification]]
* [[Ultrasound]]: Spiculated, hypoechoic lesion, shadowing, internal [[calcification]]
[[Ultrasound|Ultrasound:]]
* Spiculated, hypoechoic lesion, shadowing, internal [[calcification]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="left" style="background:#F5F5F5;" |
* [[HER2]] positive or negative
* [[Estrogen]] [[receptor]] ([[ER]])
* [[Progesterone receptor]] (PR)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Malignant]]
* May be related to genes [[BRCA1]], [[BRCA2]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Contain 25% of all [[Breast Cancer|breast cancers]]
* Approximately 25% of all [[Breast Cancer|breast cancers]]
* Increase risk with aging
* Increase risk with [[ageing]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Positive [[family history]]
* Positive [[family history]]
* nulliparity
* Nulliparity
* [[Obesity]]
* [[Obesity]]
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
Line 378: Line 310:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Noninvasive [[breast cancer]]
* Noninvasive [[breast cancer]]
* Heterogenous group of [[neoplastic]] lesions
* Heterogenous group of [[neoplastic]] lesions
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography|Mammography:]]
* Suspicious [[microcalcification]]
* Suspicious [[microcalcification]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Malignant]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Uncommon
* Rare
* Commonly referred to [[DCIS]] with microinvasion  
* Commonly referred to [[DCIS]] with microinvasion  
* Average age 50-60 years old
* Average age 50-60 years old
Line 410: Line 336:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Associated with high grade [[DCIS]]
* Associated with high grade [[DCIS]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* A mass with or without [[calcification]]
* A mass with or without [[calcification]]
* [[stromal]] reaction
* Stromal reaction
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]<ref name="pmid22451578">{{cite journal |vauthors=Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT |title=Imaging features of primary breast sarcoma |journal=AJR Am J Roentgenol |volume=198 |issue=4 |pages=W386–93 |date=April 2012 |pmid=22451578 |doi=10.2214/AJR.11.7341 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]<ref name="pmid22451578">{{cite journal |vauthors=Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT |title=Imaging features of primary breast sarcoma |journal=AJR Am J Roentgenol |volume=198 |issue=4 |pages=W386–93 |date=April 2012 |pmid=22451578 |doi=10.2214/AJR.11.7341 |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Primary: Unknown
* [[Malignant]]
* Secondary: [[Radiotherapy]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Rare type, < 1% of all breast malignancies
* Rare type, < 1% of all breast malignancies
Line 441: Line 361:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast
* Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* Noncalcified oval mass Indistinct margins
* Noncalcified oval mass Indistinct margins
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]] or
| align="center" style="background:#F5F5F5;" |±
* [[Malignant]]
| align="center" style="background:#F5F5F5;" | ±
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Most common in [[premenopausal]] women (40-50 years)
* Most common in [[premenopausal]] women (40-50 years)
Line 472: Line 388:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Nonepithelial breast [[neoplasm]] with average size of 5 cm
* Nonepithelial breast [[neoplasm]] with average size of 5 cm
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Solid mass
* Solid mass
* Hypoechoic
* Hypoechoic
* Well-circumscribed
* Well-circumscribed
[[Mammography]]:
* Smooth mass
* Polylobulated mass
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Non-Hodgkin lymphoma]]
* [[Malignant]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Extremely rare ( 0.04%-0.5%)
* Extremely rare ( 0.04%-0.5%)
Line 504: Line 418:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* Diffuse [[B cell lymphoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Diffuse growth pattern with large cells like [[immunoblast]] associated with [[neutrophils]]
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* Nonspecific circumscribed masses  
* Nonspecific circumscribed masses  
* Without [[calcification]]
* Without [[calcification]]
Line 514: Line 426:
* [[Mammography]]
* [[Mammography]]
* Core [[biopsy]]
* Core [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="Left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common among [[perimenopausal]] women
* Common among [[perimenopausal]] women
Line 532: Line 441:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Distention of subareolar ducts
* Distention of subareolar ducts
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Dilated milk ducts  
* Dilated milk ducts  
* Fluid-filled ducts
* Fluid-filled ducts
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common in women between 35-55 years old
* Common in women between 35-55 years old
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Possibly benign ones
* Possibly [[benign]]
* Harbor areas of [[atypia]] or [[DCIS]]
* Harbor areas of [[atypia]] or [[DCIS]]
* Surgical [[excision]] is recommended
* Surgical [[excision]] is recommended
Line 559: Line 463:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Solitary or multiple lesion
* Solitary or multiple lesion
* large lump near nipple
* Large lump near nipple
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Growth of papillary cell into a lumen
* Growth of papillary cell into a lumen
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Well-defined
* Well-defined
* Solid nodule
* Solid nodule
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Core needle [[biopsy]]
* Core needle [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common between age of 40-60 years old
* Common between age of 40-60 years old
Line 592: Line 491:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* Solitary tumor of mature fat cells
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Mature [[adipocytes]] without lipoblasts or [[atypia]]
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Well-Circumscribed
* Well-Circumscribed
* Hypoechoic lesion
* Hypoechoic lesion
Line 602: Line 499:
* Core needle [[biopsy]]
* Core needle [[biopsy]]
* Excisional [[biopsy]]
* Excisional [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
|
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888  }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888  }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339  }}</ref>
| align="left" style="background:#F5F5F5;" |
* Unknown
| align="center" style="background:#F5F5F5;" |+
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Small risk of [[malignancy]]
* Small risk of [[malignancy]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Result in repeating pain during mensturation
* Recurrent pain during mensturation
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* May present as a mass or incidental finding on [[mammogram]]
* May present as a mass or incidental finding on [[mammogram]]
* No treatment is needed
* No treatment is needed
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
|align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Multiple lesion
* Multiple lesion
* Firm
* Firm
Line 624: Line 518:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Proliferative disease
* Proliferative disease
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* Well-defined or irregular mass
* Well-defined or irregular mass
* [[Microcalcification]]
* [[Microcalcification]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
|-
|-
| align="center" style="background:#DCDCDC;" |Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437  }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202  }}</ref>
| align="center" style="background:#DCDCDC;" |'''Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437  }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202  }}</ref>'''
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common in reproductive age women
* Common in reproductive age women
Line 646: Line 535:
* [[Benign]] stromal [[proliferation]]
* [[Benign]] stromal [[proliferation]]
* Stimulation of vascular lesion
* Stimulation of vascular lesion
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
Line 654: Line 543:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Slit-like spaces between [[glandular]] units   
* Slit-like spaces between [[glandular]] units   
* Confused with mammary [[angiosarcoma]]
* Maybe confused with mammary [[angiosarcoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]] and [[ultrasound]]:
* Well-defined
* Well-defined
* Solid mass
* Solid mass
Line 666: Line 553:
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" |NA
|-
|-
| align="center" style="background:#DCDCDC;" |[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>
| align="center" style="background:#DCDCDC;" |'''[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>'''
| align="left" style="background:#F5F5F5;" |Complication of:
| align="left" style="background:#F5F5F5;" |
* [[Surgery]]
* [[Benign]]
* Core [[biopsy]]
* [[Radiation therapy]]
* [[Trauma]]
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Uncommon [[benign]] disease
* Uncommon [[benign]] disease
* Occur on outer side of [[breast]] or under [[nipple]]  
* Occur on outer side of [[breast]] or under [[nipple]]  
align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] and self-limiting disease
* [[Benign]] and self-limiting disease
* Resolve after 4-6 weeks
* Resolve after 4-6 weeks
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Thick and tender cord on breast skin
* Thick and tender cord on breast skin
| align="center" style="background:#F5F5F5;" |+
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
* [[Thrombophlebitis]] of [[superficial]] [[veins]] of the breast
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* N/A
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* [[Tubular]] anechoic structure  
* [[Tubular]] anechoic structure  
* Multiple narrowing areas
* Multiple narrowing areas
Line 699: Line 578:
* Clinical examination
* Clinical examination
* [[Ultrasound]]
* [[Ultrasound]]
* [[Mammography]]
| align="center" style="background:#F5F5F5;" |NA
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or<br>Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin changes
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Others
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
| align="center" style="background:#DCDCDC;" |[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>
| align="center" style="background:#DCDCDC;" |'''[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>'''
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Unknown
* [[Benign]]
* [[Autoimmune]] reaction
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Lymphocytic]] [[mastitis]] or mastopathy
* [[Lymphocytic]] [[mastitis]] or mastopathy
Line 742: Line 611:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Dense keloid-like [[fibrosis]]  
* Dense keloid-like [[fibrosis]]  
* Periductal, lobular, and perivascular [[lymphocytic]] [[Infiltration (medical)|infiltration]]
* Periductal, lobular, and perivascular [[lymphocytic]] [[Infiltration (medical)|infiltration]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Irregular mass
* Irregular mass
* Hypoechoic
* Hypoechoic
Line 754: Line 621:
* [[Ultrasound]]
* [[Ultrasound]]
* Core needle [[biopsy]]
* Core needle [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Hormonal]] imbalance
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Benign breast tissue swelling among men and boys around [[puberty]]
* Benign breast tissue swelling among men and boys around [[puberty]]
Line 776: Line 640:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Glandular]] breast changes
* [[Glandular]] breast changes
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* [[Nodular]] pattern
* [[Nodular]] pattern
* Dendritic pattern
* Dendritic pattern
Line 786: Line 648:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Systemic involvement in [[sarcoidosis]]
* [[Benign]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Rare in patients with systemic involvement
* Rare in patients with systemic involvement
Line 806: Line 665:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Idiopathic]] [[systemic]] [[granulomatous]] disorder
* [[Epithelioid]] [[granulomas]] with multinucleated [[giant cell]] with rare [[necrosis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Mammography]]:
* Irregular,
* Irregular  
* Ill-defined,
* Ill-defined
* Spiculated solid mass
* Spiculated solid mass
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Biopsy]]
* [[Biopsy]]
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Breast [[trauma]]
* [[Benign]]
* Surgical intervention
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Common among women
* Common among women
Line 840: Line 693:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Collections of liquefied fat
* Collections of liquefied fat
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |[[Ultrasound]]:
* Collections of liquefied fat
* Collections of liquefied fat
* Oil [[cysts]]
* Oil [[cysts]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Ultrasound]]
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
|}
|}
</small>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 858: Line 710:
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Primary care]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 20:42, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2], Sadaf Sharfaei M.D.[3]

Overview

Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well. Differentiating different types of breast lumps are based on imaging findings and breast clinical exam results.

Differentiating Breast lumps from other Diseases

ABBREVIATIONS
LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ

Diseases Benign or

Malignant

Clinical manifestation Paraclinical findings Gold standard diagnosis
Demography History Symptoms Signs Histopathology Imaging
Mass Mastalgia Nipple discharge Breast exam Skin changes LAP
Fibroadenoma[1] + ±
  • Solitary
  • Well-defined
  • Mobile mass
Ultrasound:
  • Well-defined
  • Solid mass
Breast cyst[2]
  • May resolve after aspiration
  • Further evaluation for unresolved masses
+ ±
  • Solitary
  • Cluster of small masses or an ill-defined mass
  • Smooth, firm, and frequently tender
  • Nonproliferative breast lesions
Ultrasound:
  • Simple cyst: Well circumscribed, posterior acoustic enhancement without internal echoes
  • Complicated cyst: Homogenous low-level internal echoes due to without solid components
  • Complex cyst: Thick walls greater than 0.5 mm with solid component
Fibrocystic change[3]
  • Unknown prevalence among adolescents
  • >50% in women of reproductive age
+ + ±
  • Nonproliferative breast lesions
Ultrasound:
  • Small cysts in mammary zone
  • Fibroglandular tissue around the mass
Galactocele[4][5] + ± ± Mammography:
  • Intermediate mass in absence of classic fat-fluid level

Ultrasound:

  • Complex mass
Cysts of montgomery[6]
  • Most common in age of 10-20 years old
  • More than 80% resolve spontaneously
  • Drainage is essential in rare cases
+ ± ±
  • Asymptomatic subareolar mass
  • Drainage of clear to brownish fluid
± Ultrasound:
  • Single cystic lesion in retroareolar area
Hamartoma[7]
  • Common in women older than 35 years old
± ± Mammography:
  • Well-described
  • Discrete, solid, and encapsulated lesion
Breast abscess[8][9]
  • Complication of lactational mastitis in 14% of cases
  • Common among African-American women, heavy smokers , and obese patients
+ + + Ultrasound:
  • Fluid collection
Mastitis[10][11] ± + ± + Breast parenchyma inflammation: Ultrasound:
  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Diseases Benign or
Malignant
Demography History Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Histopathology Imaging Gold standard diagnosis
Breast carcinoma[12][13][14]
  • Most common diagnosed cancer among women
  • Leading cause of cancer death in women 40-49 years old
+ ±
  • Hard
  • Immobile
  • Solitary
  • Irregular margin
± ± Mammography:

Ultrasound:

Ductal carcinoma in situ (DCIS)[15][16] ± ±
  • May have normal physical exam
Mammography:
Microinvasive breast cancer[17]
  • Rare
  • Commonly referred to DCIS with microinvasion
  • Average age 50-60 years old
+ ±
  • Solitary
  • Firm palpable mass
±
  • Associated with high grade DCIS
Mammography:
Breast sarcoma[18]
  • Rare type, < 1% of all breast malignancies
  • Average age of between 45-50 years
+
  • Well-defined
  • Firm mass
± Mammography:
  • Noncalcified oval mass Indistinct margins
Phyllodes tumor[19][20] ±
  • Smooth and multinodular
  • Well-defined
  • Firm mass
  • Mobile
  • Nonepithelial breast neoplasm with average size of 5 cm
Ultrasound:
  • Solid mass
  • Hypoechoic
  • Well-circumscribed

Mammography:

  • Smooth mass
  • Polylobulated mass
Lymphoma[21][22]
  • Extremely rare ( 0.04%-0.5%)
  • Average age 55-60 years
+
  • Well-defined, firm mass
  • Multiple
± Mammography:
Duct ectasia[23]
  • Usually resolve spontaneously
± ± ±
  • Usually asymptomatic
  • Distention of subareolar ducts
Ultrasound:
  • Dilated milk ducts
  • Fluid-filled ducts
Intraductal papilloma[24]
  • Common in women between 35-55 years old
+ ± ±
  • Solitary or multiple lesion
  • Large lump near nipple
  • Growth of papillary cell into a lumen
Ultrasound:
  • Well-defined
  • Solid nodule
Lipoma[25]
  • Common between age of 40-60 years old
  • Benign tumors
  • May experience recurrence
+
  • Solitary
  • Mobile
  • Soft mass
Ultrasound:
  • Well-Circumscribed
  • Hypoechoic lesion
Sclerosing adenosis[26][27]
  • Recurrent pain during mensturation
  • May present as a mass or incidental finding on mammogram
  • No treatment is needed
± +
  • Multiple lesion
  • Firm
  • Tender nodules
±
  • Proliferative disease
Mammography:
Pseudoangiomatous stromal hyperplasia[28][29]
  • Common in reproductive age women
+
  • Solitary firm mass
  • Thickening
Mammography and ultrasound:
  • Well-defined
  • Solid mass
  • Noncalcified
Mondor's disease[30][31]
  • Benign and self-limiting disease
  • Resolve after 4-6 weeks
+ +
  • Thick and tender cord on breast skin
+
  • N/A
Ultrasound:
  • Tubular anechoic structure
  • Multiple narrowing areas
Diseases Benign or
Malignant
Demography History Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Histopathology Imaging Gold standard diagnosis
Diabetic mastopathy[32]
  • Suspicious breast mass
  • After diagnosis, excision is not required
+
  • Ill-defined mass
  • Immobile
Ultrasound:
  • Irregular mass
  • Hypoechoic
  • Dense lesion
Gynecomastia[33][34]
  • Benign breast tissue swelling among men and boys around puberty
+ ± ±
  • Unilateral or bilateral firm mass
  • Breast swelling
  • Rubbery mass
Ultrasound:
Sarcoidosis[35]
  • Rare in patients with systemic involvement
+
  • Firm mass
  • Hard mass
Mammography:
  • Irregular
  • Ill-defined
  • Spiculated solid mass
Fat necrosis[36] + ±
  • Hard or smooth mass
  • Solitary mass
  • Mobile
  • Collections of liquefied fat
Ultrasound:
  • Collections of liquefied fat
  • Oil cysts

References

  1. Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
  2. Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
  3. Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
  4. Yu JH, Kim MJ, Cho H, Liu HJ, Han SJ, Ahn TG (2013). "Breast diseases during pregnancy and lactation". Obstet Gynecol Sci. 56 (3): 143–59. doi:10.5468/ogs.2013.56.3.143. PMC 3784111. PMID 24327995.
  5. Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
  6. De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
  7. Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
  8. D'Alfonso TM, Ginter PS, Shin SJ (2015). "A Review of Inflammatory Processes of the Breast with a Focus on Diagnosis in Core Biopsy Samples". J Pathol Transl Med. 49 (4): 279–87. doi:10.4132/jptm.2015.06.11. PMC 4508565. PMID 26095437.
  9. Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
  10. Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
  11. Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
  12. Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
  13. Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
  14. Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
  15. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
  16. Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
  17. Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
  18. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
  19. Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
  20. Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
  21. Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
  22. Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
  23. Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
  24. Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
  25. Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
  26. Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
  27. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
  28. Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
  29. Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
  30. Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
  31. Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
  32. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB (2002). ""Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes". Diabetes Care. 25 (1): 121–6. PMID 11772912.
  33. Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011). "Ultrasonography of the male breast". J Ultrasound. 14 (3): 122–9. doi:10.1016/j.jus.2011.06.004. PMC 3558246. PMID 23397020.
  34. Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
  35. Lower EE, Hawkins HH, Baughman RP (2001). "Breast disease in sarcoidosis". Sarcoidosis Vasc Diffuse Lung Dis. 18 (3): 301–6. PMID 11587103.
  36. Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.


Template:WikiDoc Sources